Nagoya City University
Clinical trials sponsored by Nagoya City University, explained in plain language.
-
New combo therapy shows promise for tough breast cancer
Disease control Recruiting nowThis study tests a combination of two drugs, ribociclib and anastrozole, in people with a common type of advanced breast cancer (HR-positive, HER2-negative) that has spread or come back. The goal is to see if the combo can shrink tumors and how safe it is. About 86 adults in Japa…
Phase: PHASE1, PHASE2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New breast cancer trial aims to wipe out tumors before surgery
Disease control Recruiting nowThis study tests whether adding new drugs to standard chemotherapy before surgery can eliminate early-stage breast cancer (stage II-III) more effectively. About 100 participants will receive either standard treatment or an experimental combination. The main goal is to see if the …
Phase: PHASE2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC